What is Diclofenac Sodium?
Diclofenac sodium is a non-steroidal anti-inflammatory drug, is a slightly yellowish crystalline powder or white. It is used to relieve pain, swelling, and joint stiffness caused by arthritis. It comes as tablets, capsules, and suppositories and is available on prescription only. Gel and plasters for joint pain are available from pharmacies. It is sold with brand name Voltaren, Arthrotec and Solaraze.
Global Diclofenac Sodium Market Outlook
Diclofenac is primarily used to treat arthritis and inflammatory pain caused by surgery or injury. The increasing aging population and surgeries practices are driving the diclofenac sodium market. Disorders of the musculo-skeletal system affect 70% of the population over the age of 50 years. Patients with chronic pain evaluated at a minimum of 50% percent on the visual analog scale are eligible for therapy with high-potency opioids. At all stages of pain treatment, diclofenac sodium can be used in combination with co- diclofenac sodium including sedatives, antidepressants, and anti-epileptics which may contribute to a reduction in doses of diclofenac sodium drugs.
Diclofenac sodium is the most commonly used painkiller, but in recent years is experiencing a tragic fall of sale owing to the associated risk of heart problems. Diclofenac Sodium is removed from over the counter from several countries. Researchers suggest that diclofenac should be available only with a prescription, also should be accompanied by an appropriate front package warning about its potential risks.
Global Diclofenac Sodium Market Competitive Landscape
The "Global Diclofenac Sodium Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as Auro Laboratories Limited, Henan Dongtai Pharmaceutical Co., Bayer AG, Pfizer Inc., Hunan Warrant Pharmaceutical Co., Ltd, Novartis AG, XianShi Pharmaceutical Group, Merck & Co., Inc., Istituto Biochimico Italiano G. Lorenzini S.p.A., and Dezhou Deyao Pharmaceutical Co., Ltd. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
1. INTRODUCTION OF GLOBAL DICLOFENAC SODIUM MARKET
1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions
2. EXECUTIVE SUMMARY
3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources
4. GLOBAL DICLOFENAC SODIUM MARKET OUTLOOK
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. GLOBAL DICLOFENAC SODIUM MARKET, BY TYPE
5.1. Overview
5.2. Tablet
5.3. Injection
6. GLOBAL DICLOFENAC SODIUM MARKET, BY APPLICATION
6.1. Overview
6.2. Elderly
6.3. Adults
7. GLOBAL DICLOFENAC SODIUM MARKET, BY GEOGRAPHY
7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. Germany
7.3.2. U.K.
7.3.3. France
7.3.4. Rest of Europe
7.4. Asia Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia Pacific
7.5. Rest of the World
7.5.1. Latin America
7.5.2. Middle East & Africa
8. GLOBAL DICLOFENAC SODIUM MARKET COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Company Market Ranking
8.3. Key Development Strategies
9. COMPANY PROFILES
9.1. Auro Laboratories Limited
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
9.2. Henan Dongtai Pharmaceutical Co.
9.2.1. Overview
9.2.2. Financial Performance
9.2.3. Product Outlook
9.2.4. Key Developments
9.3. Bayer AG
9.3.1. Overview
9.3.2. Financial Performance
9.3.3. Product Outlook
9.3.4. Key Developments
9.4. Pfizer Inc.
9.4.1. Overview
9.4.2. Financial Performance
9.4.3. Product Outlook
9.4.4. Key Developments
9.5. Hunan Warrant Pharmaceutical Co.
9.5.1. Overview
9.5.2. Financial Performance
9.5.3. Product Outlook
9.5.4. Key Developments
9.6. Novartis AG
9.6.1. Overview
9.6.2. Financial Performance
9.6.3. Product Outlook
9.6.4. Key Developments
9.7. XianShi Pharmaceutical Group
9.7.1. Overview
9.7.2. Financial Performance
9.7.3. Product Outlook
9.7.4. Key Developments
9.8. Merck & Co., Inc.
9.8.1. Overview
9.8.2. Financial Performance
9.8.3. Product Outlook
9.8.4. Key Developments
9.9. Istituto Biochimico Italiano G. Lorenzini S.p.A.
9.9.1. Overview
9.9.2. Financial Performance
9.9.3. Product Outlook
9.9.4. Key Developments
9.10. Dezhou Deyao Pharmaceutical Co., Ltd.
9.10.1. Overview
9.10.2. Financial Performance
9.10.3. Product Outlook
9.10.4. Key Developments
10. Appendix
10.1. Related Reports
This report gives an insight into the global Sodium Reduction Ingredients Market and predicts the future growth prospects and the trends that may exhibit in the market during the period of 2023-2030. The future growth has been calculated by taking into account the present growth rate and the overall...
The global Sodium Laureth-4 Carboxylate (SLE4C) market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market...
The global Sodium Cocamphoacetate market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in th...
The global Lasalocid Sodium Reagent market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...
The global Sulfachloropyridazine Sodium market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players...
The global Cloprostenol Sodium Salt Reagent market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pla...
The global Bromaminic Acid Sodium Salt (Cas 6258-06-6) market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help...
The global Sodium Tetrafluoroborate market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...
The global Sodium Valproate market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fie...
The global Enoxaparin Sodium market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fi...